Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Snowsill, T."" wg kryterium: Autor


Wyświetlanie 1-16 z 16
Tytuł :
Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Yang H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Griffin E; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Robinson S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.; Exeter Test Group, University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2018 Nov; Vol. 22 (69), pp. 1-276.
Typ publikacji :
Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Early Detection of Cancer*
Mass Screening*
Tomography, X-Ray Computed*
Lung Neoplasms/*diagnostic imaging
Humans ; Quality-Adjusted Life Years ; Technology Assessment, Biomedical ; Treatment Outcome
Raport
Tytuł :
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Frayling IM; Institute of Cancer and Genetics, University Hospital of Wales, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Sep; Vol. 21 (51), pp. 1-238.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Genetic Testing*/economics
Genetic Testing*/methods
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; DNA Mismatch Repair ; Endometrial Neoplasms ; England ; Female ; Humans ; Microsatellite Instability ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Autorzy :
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Tikhonova I; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Peters J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Jun; Vol. 21 (38), pp. 1-294.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Treatment Outcome*
Antibodies, Monoclonal/*administration & dosage
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*administration & dosage
Antineoplastic Agents/*economics
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Agents, Immunological/*economics
Cetuximab/*administration & dosage
Cetuximab/*economics
Colorectal Neoplasms/*drug therapy
Neoplasm Metastasis/*drug therapy
Cost-Benefit Analysis ; Female ; Humans ; Male ; Panitumumab ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Autorzy :
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Peters J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Moore J; Exeter Kidney Unit, Royal Devon and Exeter Foundation Trust Hospital, Exeter, UK.
Allwood M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Lowe J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Anderson R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Aug; Vol. 20 (62), pp. 1-594.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Immunosuppressive Agents/*economics
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*methods
Abatacept/economics ; Abatacept/therapeutic use ; Antibodies, Monoclonal ; Antilymphocyte Serum ; Basiliximab ; Bayes Theorem ; Cost-Benefit Analysis ; Everolimus/economics ; Everolimus/therapeutic use ; Graft Rejection/prevention & control ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Models, Economic ; Mycophenolic Acid/economics ; Mycophenolic Acid/therapeutic use ; Quality of Life ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic ; Recombinant Fusion Proteins ; Sirolimus/economics ; Sirolimus/therapeutic use ; Tacrolimus/economics ; Tacrolimus/therapeutic use ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Autorzy :
Haasova M; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Lowe J; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Dudley J; Department of Paediatric Nephrology, Bristol Royal Hospital for Children (University Hospitals Bristol NHS Foundation Trust), Bristol, UK.
Marks S; Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Anderson R; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Aug; Vol. 20 (61), pp. 1-324.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Immunosuppressive Agents/*economics
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*methods
Abatacept/therapeutic use ; Antibodies, Monoclonal/economics ; Antibodies, Monoclonal/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Azathioprine/economics ; Azathioprine/therapeutic use ; Basiliximab ; Child ; Clinical Trials as Topic ; Cost-Benefit Analysis ; Drug Therapy, Combination ; Everolimus/therapeutic use ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Models, Economic ; Mycophenolic Acid/therapeutic use ; Recombinant Fusion Proteins/economics ; Recombinant Fusion Proteins/therapeutic use ; Sirolimus/therapeutic use ; Tacrolimus/economics ; Tacrolimus/therapeutic use ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Autorzy :
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Medina-Lara A; University of Exeter Medical School, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter Hospital, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Feb; Vol. 20 (13), pp. 1-588, v-vi.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Technology Assessment, Biomedical*
Anemia/*drug therapy
Hematinics/*therapeutic use
Neoplasms/*drug therapy
Anemia/economics ; Anemia/etiology ; Hematinics/economics ; Humans ; Models, Economic ; Neoplasms/economics ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
Autorzy :
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Meng Y; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Mújica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2015 Jan; Vol. 19 (2), pp. v-xxv, 1-215.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Breast Neoplasms/*pathology
Lymph Nodes/*pathology
Nucleic Acid Amplification Techniques/*methods
Axilla ; Cost-Benefit Analysis ; England ; Humans ; Intraoperative Period ; Lymphatic Metastasis ; Quality of Life ; Quality-Adjusted Life Years ; Sensitivity and Specificity ; Sentinel Lymph Node Biopsy ; State Medicine
Czasopismo naukowe
Tytuł :
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Frayling I; Institute of Medical Genetics, Cardiff University, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2014 Sep; Vol. 18 (58), pp. 1-406.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Aged ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Cost-Benefit Analysis ; Genetic Testing/economics ; Genetic Testing/methods ; Humans ; Middle Aged
Czasopismo naukowe
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies